ArticlePDF Available

Craniofacial growth and development of Turner syndrome children

Authors:

Abstract and Figures

Turner syndrome is a genetic disorder which characterized by specific physical appearance and the lost of one of sex chromosome in females. The most frequent chromosome constitution in Turner syndrome is 45X. This disorder may cause an interruption of growth and development in the whole body as well as in the craniofacial region. The oral manifestations of Turner syndrome are micrognathia, high palate, malocclusion, and the premature eruption of first permanent molars. This paper will discuss the oral manifestations associated with the craniofacial growth and development of Turner syndrome.
Content may be subject to copyright.
Craniofacial growth and development of Turner syndrome children (Inne Suherna S. et al.)
127
Craniofacial growth and development of
Turner syndrome children
Inne Suherna Sasmita*, Arlette Suzy Puspa Pertiwi*, M. Harun Achmad**
*Department of Pediatric Dentistry Faculty of Dentistry Universitas Padjadjaran
**Department of Pediatric Dentistry Faculty of Dentistry Universitas Hasanudin
ABSTRACT
Turner syndrome is a genetic disorder which characterized by specic physical appearance and
the lost of one of sex chromosome in females. The most frequents chromosome constitution in Turner
syndrome is 45X. This disorder may cause an interruption of growth and development in the whole body
as well as in the craniofacial region. The oral manifestations of Turner syndrome are micrognathia, high
palate, malocclusion, and premature eruption of rst permanent molars. This paper will discuss the oral
manifestations associated with the craniofacial growth and development of Turner syndrome.
Key words: Turner syndrome, sex chromosome, craniofacial
INTRODUCTION
Turner syndrome is a genetic disorder in
female which characterized by special physical
features and the lost of all or a part of secondary
sex chromosome. The disorder may lead to a
group of physical nding including congenital
lymphoedema, short stature, and gonadal
dysgenesis.1,2
History of Turner syndrome begun at 1938
when Henry Turner, an endocrinologist from
Oklahoma, found seven patients age about fteen
to twenty three came with a problem of dwarsm
and delayed sexual development. Patient did not
respond to the therapy with pituitary extract.3
Incidence of Turner syndrome is 1:2000-
2500 live birth female. It is a rare disorder and
characterized by decreased sexual development
at puberty. Other features are abnormalities
in the heart, kidneys, and other malformations
since the syndrome affects many system organ.3,4
Increase of chromosome abnormality commonly
occurs in children who are born from parents with
advanced age, but this does not occur in turner
syndrome cases. Main cause of the lost of all or a
part of X-chromosome is unknown (Fig. 1).5 Short
stature is a common sign of Turner syndrome and
occurs almost 100% of cases. Short stature may
cause an increase of unbalance body weight,
which may lead to a high risk of obesity related
disease. Growth deciency occurs especially in
lower extremities as oppose to upper resulted a
short feet appearance.3
Ovarian dysgenesis is related to the abnormal
growth of ovary and occurs in 95% cases. This may
lead to a delayed or lost of sexual development
when the patient enters puberty. Incidence of
patients who have spontaneous puberty signs
at adolescent is 12%. Patients usually develop
amenorrhea. Several teenagers will experience
Correspondence author: Inne Suherna Sasmita, Department of Pediatric Dentistry Faculty of Dentistry Universitas Padjad-
jaran Jl. Sekeloa Selatan No. 1 Bandung, West Java-Indonesia, Tel./Fax: +6222-2504985/2532805
128
Padjadjaran Journal of Dentistry 2009;21(2):127-131.
Figure 1. Characteristic of Turner syndrome.3
Figure 2. Comparative size of craniofacial in Turner
syndrome and normal population.10
Figure 3. Patients’ prole.3
Figure 5. Enamel hypoplasia of Turner syndrome child.11
Figure 6. Panoramic radiograph of Turner syndrome at the
age of 8 showed premature loss in primary dentition and
premature eruption od permanent dentition.
Craniofacial growth and development of Turner syndrome children (Inne Suherna S. et al.)
129
menstruation then there was a disturbance in the
gonad which may lead to stop growth of ovary.
Teenagers with spontaneous pubertal development
have the risk of premature menopause.3
Growth and development of Turner
syndrome is later than normal girl in almost all
periods. Delayed in the increase of body height
is the main reason for a parent to bring their
undiagnosed child to seek for help. After birth,
patients have a height of a few centimeters below
normal compare to normal babies. The rate of
increase body height is later after two years of
age, leading to short stature.5
Tu r ne r s y n dr o m e i s d i ag n o s ed b y g e ne t ic
examination, since it is a genetic disorder. Diagnostic
test is done by examining chromosome pattern in the
blood samples which called caryotiping. Prenatally,
diagnosis can be done by amniocentesis.3
Craniofacial growth and development of Turner
syndrome
Child with Turner syndrome has a different
growth and development compare to normal child,
generally. Bone formations undergo abnormal
process. The abnormalities are delayed skeletal
maturation, small bone, and reduced of Bone
Mineral Density (BMD). Factors which affecting
the abnormal growth and development are mainly
cause by hormone and genetic.3
Craniofacial of Turner syndrome compare
to normal child shows delayed development of
cranium, reduced size of craniofacial complex,
facial retrognathia, increased incisors overjet,
reduced overbite, class II malocclusion, and
abnormality of jaws relationships.6
Disturbance of bone growth in Turner
syndrome is the result of skeletal dysplasia
which may lead to short stature, slight ephyseal
dysplasia, and abnormal bone formations. Skeletal
dysplasia occurs because there is deciency in the
gene that brings SHOX. These also lead to delayed
bone formation and short stature.1
SHOX protein is a group of cells which play
an important role in chondrogenesis process.
One of the reason why Turner syndrome child
have short stature is because one or a part of X
chromosome is missing leading to the lost of active
SHOX.3 Blocked chondrogenesis process may also
block the growth of craniofacial, since the growth
of skull and jaws insist of three main mechanism,
which are the growth of cartilage, suture, and
periosteal and endosteal.7
Cartilage growth in the skull is mainly
occurs in basis cranii, nasal septal, and mandibular
condyles. Cartilage growth at spheno-occipital
synchondrosis may increase the antero-posterior
dimension of basis cranii. Every area of cartilage
growth plays an important role in the growth of
Figure 4. Palatal arch of Turner syndrome: (1) Normal; (2) Mild; (3) Moderate; (4) Severe.3
12
34
130
Padjadjaran Journal of Dentistry 2009;21(2):127-131.
head, especially in the rst year of life.7
Gonadal dysplasia which occurs in Turner
syndrome may lead to a deciency in the secretion
of estrogen hormone. The hormone is produce
by ovary and stimulate the development of sex
organs in females, breast, and variable secondary
sex characteristics. It also affects to the growth
and development of bone. Estrogen increased
the osteoblastic activities and affects the growth
of skeletal bone by causing the early union of
ephysise with the body of long bones.8
In normal individuals, the secretion of
estrogen hormone will reduce along with the
increase of age and stops after menopause.
Deciency in estrogen level may result as reduced of
osteoblastic activities in the bone, bone matrix, and
the deposit of calcium and phosphate in the bone.8
Generally, Turner syndrome patients
experience the deciency of estrogen before,
during, and after puberty. Estrogen in the
prepuberty period function as in the increase
of bone size which does not happened in Turner
syndrome. Low secretion of estrogen may cause
delayed bone growth.9
Study of 32 Turner syndrome children aged
7-16.7 compare to 33 normal girls aged 10.2-
16.7 by Midtbo and Halse10 showed different size
of calvaria and face. Calvaria and face in Turner
syndrome girls showed a smaller size (Fig. 2).
This morphology is characterized by at cranial
angle, shortened posterior cranial base, facial
retrognathy, and rotation of jaws. These results
showed a deviation in the pattern of the size and
morphology of craniofacial in this syndrome which
already exists since chilhood.
Jaws growth and development of Turner
syndrome
Sixty percent of Turner syndrome patient
have micrognathia. Generally, this occurs in
mandible, thus showed a feature that lower jaw is
retrognathia and upper jaw is normal or prognathia
(Fig. 3). Another feature showed an abnormality
in the growth of palate. This shows a high palatal
arch in the form of U or V (Fig. 4). This case occurs
in about 80% Turner syndrome and may lead to
skeletal class II malocclusion.3,11
Dental implications of Turner syndrome
Malocclusion is one of clinical sign of
Turner syndrome. Another dental implications are
smaller size of tooth crown, abnormal quantity of
roots, enamel hypoplasia (Fig. 5), thin dentine,
posterior open bite, cross bite, premature
eruption of permanent dentition, and delayed
tooth maturation.11,12
Dental eruption in Turner syndrome girls
usually 3.7 months faster than normal. Premature
eruption in permanent dentition especially occurs
in rst molars at the age of 4, normally at the age
of 6 (Fig. 6).11,13
Management of Turner syndrome
Generally, Turner syndrome patients are
under supervision by endocrinologist for routine
check up and therapies. Therapy for Turner
syndrome includes growth hormon therapy
followed by estrogen injection. Growth hormone
therapy is aimed to enhance linear growth.
Estrogen therapy is necessary to make Turner
syndrome girl more feminine, delay osteoporosis
process, and stimulate the development of
secondary sex characteristic.3
Other than main therapy, which are growth
hormone and estrogen therapy, endocrinologist
also give a supportive therapy. The later consist
of anabolic steroid, antihypertension, vitamin and
mineral, and thyroid therapy.14
CONCLUSION
Turner syndrome causes a disturbance in
growth and development of the body which affects
the growth and development of craniofacial
complex. Growth hormone therapy gives a
signicant result in the growth and development of
bone, but it does not correct the abnormalities in
dental morphology and eruption. The management
of craniofacial abnormalities in Turner syndrome
can be managed by the cooperation of pedodontist,
orthodontist, and endodontist.
REFERENCES
Sybert VP, McCauley E. Turner’s syndrome.
New England J Med 2004;351:1227-38.
Saenger P. Turner’s syndrome. New England J
Med 1996;355:1749-54.
Ross JL, Dennis-Feezle, Weber C. Turner
syndrome: toward early recognition and
1.
2.
3.
Craniofacial growth and development of Turner syndrome children (Inne Suherna S. et al.)
131
improved outcomes. �cited 2005 Nov 28�cited 2005 Nov 28
Available from: http//www.medscape.com.
Ploof S. Turner’s syndrome denition. �cited�cited
2005 Nov 28. Available from: http//www. Available from: http//www.
turner’s syndrome.htm.
Nielsen J, Naeraa RW. Turner’s syndrome and
Turner contact group. �cited 2005 Nov 28�cited 2005 Nov 28
Available from: http//www.aaa.dk.
Davenport ML. The effect of growth hormone
on craniofacial growth and dental maturation
in turner syndrome. The Angle orthodontist
2001;71(1):50-9.
Foster TD. A textbook of orthodontics. 3rd ed.
Jakarta: EGC; 1999. p. 1-20,68.
Guyton, Hall. Textbook of medical physiology.
Jakarta: EGC; 1996.
Rubin K. Turner syndrome and osteoporosis:
mechanisms and prognosis. Pediatrics
4.
5.
6.
7.
8.
9.
1998;102(2):481-5.
Midtbo M, Wisth PJ, Halse A. Craniofacial
morphology in young patients with Turner
syndrome. Eur J Orthod 1996;18(3):215-25.
Carter VL. The treatment complexities of
Turner’s syndrome patients (case studies) Dent
Hygiene 2003;1(1).
Simmons KE. Growth hormone and
craniofacial changes: preliminary data from
studies in Turner’s syndrome. Pediatrics
1999;104(4):1021-4.
Szilagyi A, Keszthelyi G, Nagy G, Madlena.
Oral manifestations of patients with Turner
syndrome. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 2000;89(5):577-84.
Postellon D. Turner syndrome. �cited 2005 Nov�cited 2005 Nov
28. Available from: http//www.emedicine.Available from: http//www.emedicine.
com.
10.
11.
12.
13.
14.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
The craniofacial morphology of 33 Turner syndrome patients, aged 7-16.7 years, was evaluated by standard cephalometric methods. The sample was subdivided according to karyotype and 72 normal girls aged 7.1-16.1 years served as controls. The size of the calvarium and face was generally smaller in the Turner group than in the controls. The morphology was characterized by a flattened cranial base angle, a marked reduction in posterior cranial base length, facial retrognathism and short and posteriorly rotated jaws. The same morphological pattern was found in all the karyotypes, but the deviations were most pronounced in monosomy X (45X) patients. The results indicate that a deviating pattern of craniofacial size and morphology has already been established in childhood. It is suggested that the deviations originate in the fetal period, when the primary cartilages form the craniofacial skeleton.
Article
Despite only limited reports of a greater number of fractures during childhood or adulthood, osteoporosis historically has been described as a feature in Turner syndrome, because of the frequent observation of radiographic osteopenia and the coarse trabecular pattern of the carpal bones on radiographs. The pathogenesis of the skeletal demineralization remains unclear, but the data support the concept of an intrinsic bone defect that is then exacerbated by a number of hormonal factors, including the growth-regulating hormones, the gonadal steroids, and possibly the calcium-regulating hormones. The advent of more refined methods, such as single- and dual-photon absorptiometry and dual energy x-ray absorptiometry, has led to improved insights into bone mineral density (BMD) status in Turner syndrome (TS). A major limitation of these projection methods is that they report areal and not true volumetric BMD, resulting in an underestimation of the true BMD in smaller subjects. In assessing BMD in TS, various methods have been used to eliminate the confounding effect of bone size. Some consistent patterns do emerge in persons with TS who are not treated with long-term growth hormone (GH) or estrogen therapy. A significant deficit in cortical bone commonly appears in childhood and usually is associated with a low bone-turnover state. Significant osteopenia at predominantly trabecular sites develops during mid- to late adolescence and persists into adulthood, when it is associated with increased bone turnover. Preliminary BMD data on patients after long-term GH therapy show an absence of osteopenia. With respect to the impact of long-term estrogen therapy, the BMD deficit in adults with TS who have been treated adequately with estrogen, but who have not been treated with GH, is less than it is in those who have been insufficiently treated or not treated at all with estrogen. The available data indicate that long-term GH treatment during the prepubertal and early to midpubertal years optimizes BMD and improves the prognosis for adequate peak bone mass being achieved after a puberty that, most often, has been induced with exogenous estrogen. Long-term treatment with estrogen and progestin that is initiated during mid- to late adolescence and is continued throughout adulthood appears necessary for a normal peak bone mass to be achieved and the BMD to be preserved well beyond the time of peak bone mass. Additional measures to prevent osteoporosis must be used, such as ensuring adequate calcium intake and ample weight-bearing activities, focusing on preventing injuries and avoiding overtreatment with thyroid hormones. Long-term surveillance with measurement of BMD and of bone turnover in a large TS population into their later adult years is necessary before it can be concluded that the osteopenia observed in TS is a nonprogressive asymptomatic bone defect of no clinical consequences.
Article
Normal craniofacial and dental growth and development is dependent on growth hormone (GH) and insulin-like growth factor I (IGF-I). Deficiencies of either during childhood cause diminished growth of the maxilla and (to a greater degree) the mandible. Dental development/eruption also is compromised. Conversely, excessive GH/insulin-like growth factor I causes overgrowth, with the mandible again more affected than the maxilla. Replacement therapy in deficiency conditions generally normalizes craniofacial growth. Systemic GH also has been used in other disorders for which overt deficiency of GH has not been demonstrated. One such condition, Turner's syndrome, is now widely treated with GH. Although systemic GH in Turner's syndrome has been shown to positively affect stature, the effects on craniofacial growth and dental development/eruption are largely unknown. To explore these issues, standardized lateral radiographs of seven untreated patients with Turner's syndrome were analyzed and revealed hypoplasias of the cranial base, maxilla, and mandible. Dental development/eruption of patients with Turner's syndrome was found to be significantly advanced (by 0.63 years), relative to control subjects, in a separate study. Annual radiocephalometric measurements of 19 patients with Turner's syndrome treated with GH were compared with nonaffected control subjects over 1 year of treatment. Compared with age-matched historic control subjects, all maxillary-and most mandibular-growth measures were within 2 standard deviations of control. However, in our patients with Turner's syndrome, we found two measures of mandibular growth that deviated by more than 3 standard deviations from control. These data, although preliminary and only encompassing a short period, indicate that mandibular growth may be more affected than is maxillary growth by GH treatment and should be monitored over long-term-therapy.
Article
Serial cephalometric and panoramic radiographs from a mixed longitudinal group of 28 subjects with Turner syndrome (TS), age 4.4-19.0 years, were evaluated for annualized growth increments of the craniofacial complex and dental development and were compared with a longitudinal control group from the Burlington growth study. The short and retrognathic face characteristic of the syndrome was due largely to the increased cranial base angle, decreased posterior face height, and decreased mandibular length, all of which were significantly different from the controls. Although increases in statural height occurred in the TS children who were treated with human growth hormone (GH), there was little or no effect on growth of the jaws, particularly in the older subjects, and the characteristic facies of the syndrome persisted. Dental development was advanced in all TS subjects, and GH administration had no effect on the rate of dental development.
Article
Management of the chromosomal condition Turner's syndrome requires consistent medical care, especially during the time when affected girls transition from childhood into adulthood. The medical problems that first develop during childhood of a patient with Turner's syndrome such as congenital heart disease, hearing loss, skeletal problems and dental and ophthalmological abnormalities, should be followed into adulthood. Providing the necessary continuum of care will require that medical centers develop teams with the appropriate expertise in treatment of Turner's syndrome. Now more than ever patients with Turner's syndrome have the capability of achieving their full potential, but it requires a multidisciplinary approach toward care throughout their lifetime.
Article
Most children with Turner's syndrome are under the care of specialists. It has been proposed that adults should also be followed in multidisciplinary specialty clinics. We believe, on the basis of our own experience, that most affected women can best be served by their primary care practitioners, with the use of informed judgment about the need for referral to specialists. Although these women have substantial health concerns, their care for the most part falls under the standard repertoire of primary care, and continued follow-up in specialty care centers may inhibit their integration into society and foster a sense of ill-being. Support groups for patients with Turner's syndrome and their families (listed in the Appendix) can be a source of valuable information.
Turner syndrome: toward early recognition and
  • J L Ross
  • Dennis-Feezle
  • C Weber
Ross JL, Dennis-Feezle, Weber C. Turner syndrome: toward early recognition and . �cited 2005 Nov 28�� �cited 2005 Nov 28�� Available from: http//www.medscape.com.
Turner's syndrome definition
  • S Ploof
Ploof S. Turner's syndrome definition. �cited �cited 2005 Nov 28��. Available from: http//www. Available from: http//www. turner's syndrome.htm.
Turner's syndrome and Turner contact group
  • J Nielsen
  • R W Naeraa
Nielsen J, Naeraa RW. Turner's syndrome and Turner contact group. �cited 2005 Nov 28�� �cited 2005 Nov 28�� Available from: http//www.aaa.dk.